Cargando…
Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
In Duchenne muscular dystrophy (DMD), lack of dystrophin increases the permeability of myofiber plasma membranes to ions and larger macromolecules, disrupting calcium signaling and leading to progressive muscle wasting. Although the biological origin and meaning are unclear, alterations of phosphati...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791236/ https://www.ncbi.nlm.nih.gov/pubmed/35095541 http://dx.doi.org/10.3389/fphys.2021.698166 |
_version_ | 1784640162264776704 |
---|---|
author | Valentine, William J. Mostafa, Sherif A. Tokuoka, Suzumi M. Hamano, Fumie Inagaki, Natsuko F. Nordin, Joel Z. Motohashi, Norio Kita, Yoshihiro Aoki, Yoshitsugu Shimizu, Takao Shindou, Hideo |
author_facet | Valentine, William J. Mostafa, Sherif A. Tokuoka, Suzumi M. Hamano, Fumie Inagaki, Natsuko F. Nordin, Joel Z. Motohashi, Norio Kita, Yoshihiro Aoki, Yoshitsugu Shimizu, Takao Shindou, Hideo |
author_sort | Valentine, William J. |
collection | PubMed |
description | In Duchenne muscular dystrophy (DMD), lack of dystrophin increases the permeability of myofiber plasma membranes to ions and larger macromolecules, disrupting calcium signaling and leading to progressive muscle wasting. Although the biological origin and meaning are unclear, alterations of phosphatidylcholine (PC) are reported in affected skeletal muscles of patients with DMD that may include higher levels of fatty acid (FA) 18:1 chains and lower levels of FA 18:2 chains, possibly reflected in relatively high levels of PC 34:1 (with 16:0_18:1 chain sets) and low levels of PC 34:2 (with 16:0_18:2 chain sets). Similar PC alterations have been reported to occur in the mdx mouse model of DMD. However, altered ratios of PC 34:1 to PC 34:2 have been variably reported, and we also observed that PC 34:2 levels were nearly equally elevated as PC 34:1 in the affected mdx muscles. We hypothesized that experimental factors that often varied between studies; including muscle types sampled, mouse ages, and mouse diets; may strongly impact the PC alterations detected in dystrophic muscle of mdx mice, especially the PC 34:1 to PC 34:2 ratios. In order to test our hypothesis, we performed comprehensive lipidomic analyses of PC and phosphatidylethanolamine (PE) in several muscles (extensor digitorum longus, gastrocnemius, and soleus) and determined the mdx-specific alterations. The alterations in PC 34:1 and PC 34:2 were closely monitored from the neonate period to the adult, and also in mice raised on several diets that varied in their fats. PC 34:1 was naturally high in neonate’s muscle and decreased until age ∼3-weeks (disease onset age), and thereafter remained low in WT muscles but was higher in regenerated mdx muscles. Among the muscle types, soleus showed a distinctive phospholipid pattern with early and diminished mdx alterations. Diet was a major factor to impact PC 34:1/PC 34:2 ratios because mdx-specific alterations of PC 34:2 but not PC 34:1 were strictly dependent on diet. Our study identifies high PC 34:1 as a consistent biochemical feature of regenerated mdx-muscle and indicates nutritional approaches are also effective to modify the phospholipid compositions. |
format | Online Article Text |
id | pubmed-8791236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87912362022-01-27 Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle Valentine, William J. Mostafa, Sherif A. Tokuoka, Suzumi M. Hamano, Fumie Inagaki, Natsuko F. Nordin, Joel Z. Motohashi, Norio Kita, Yoshihiro Aoki, Yoshitsugu Shimizu, Takao Shindou, Hideo Front Physiol Physiology In Duchenne muscular dystrophy (DMD), lack of dystrophin increases the permeability of myofiber plasma membranes to ions and larger macromolecules, disrupting calcium signaling and leading to progressive muscle wasting. Although the biological origin and meaning are unclear, alterations of phosphatidylcholine (PC) are reported in affected skeletal muscles of patients with DMD that may include higher levels of fatty acid (FA) 18:1 chains and lower levels of FA 18:2 chains, possibly reflected in relatively high levels of PC 34:1 (with 16:0_18:1 chain sets) and low levels of PC 34:2 (with 16:0_18:2 chain sets). Similar PC alterations have been reported to occur in the mdx mouse model of DMD. However, altered ratios of PC 34:1 to PC 34:2 have been variably reported, and we also observed that PC 34:2 levels were nearly equally elevated as PC 34:1 in the affected mdx muscles. We hypothesized that experimental factors that often varied between studies; including muscle types sampled, mouse ages, and mouse diets; may strongly impact the PC alterations detected in dystrophic muscle of mdx mice, especially the PC 34:1 to PC 34:2 ratios. In order to test our hypothesis, we performed comprehensive lipidomic analyses of PC and phosphatidylethanolamine (PE) in several muscles (extensor digitorum longus, gastrocnemius, and soleus) and determined the mdx-specific alterations. The alterations in PC 34:1 and PC 34:2 were closely monitored from the neonate period to the adult, and also in mice raised on several diets that varied in their fats. PC 34:1 was naturally high in neonate’s muscle and decreased until age ∼3-weeks (disease onset age), and thereafter remained low in WT muscles but was higher in regenerated mdx muscles. Among the muscle types, soleus showed a distinctive phospholipid pattern with early and diminished mdx alterations. Diet was a major factor to impact PC 34:1/PC 34:2 ratios because mdx-specific alterations of PC 34:2 but not PC 34:1 were strictly dependent on diet. Our study identifies high PC 34:1 as a consistent biochemical feature of regenerated mdx-muscle and indicates nutritional approaches are also effective to modify the phospholipid compositions. Frontiers Media S.A. 2022-01-12 /pmc/articles/PMC8791236/ /pubmed/35095541 http://dx.doi.org/10.3389/fphys.2021.698166 Text en Copyright © 2022 Valentine, Mostafa, Tokuoka, Hamano, Inagaki, Nordin, Motohashi, Kita, Aoki, Shimizu and Shindou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Valentine, William J. Mostafa, Sherif A. Tokuoka, Suzumi M. Hamano, Fumie Inagaki, Natsuko F. Nordin, Joel Z. Motohashi, Norio Kita, Yoshihiro Aoki, Yoshitsugu Shimizu, Takao Shindou, Hideo Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle |
title | Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle |
title_full | Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle |
title_fullStr | Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle |
title_full_unstemmed | Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle |
title_short | Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle |
title_sort | lipidomic analyses reveal specific alterations of phosphatidylcholine in dystrophic mdx muscle |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791236/ https://www.ncbi.nlm.nih.gov/pubmed/35095541 http://dx.doi.org/10.3389/fphys.2021.698166 |
work_keys_str_mv | AT valentinewilliamj lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT mostafasherifa lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT tokuokasuzumim lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT hamanofumie lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT inagakinatsukof lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT nordinjoelz lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT motohashinorio lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT kitayoshihiro lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT aokiyoshitsugu lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT shimizutakao lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle AT shindouhideo lipidomicanalysesrevealspecificalterationsofphosphatidylcholineindystrophicmdxmuscle |